| Literature DB >> 28374764 |
Xiaoyue Ma1, Yan Bai1, Yusong Lin2, Xiaohua Hong3, Taiyuan Liu1, Lun Ma1, E Mark Haacke4, Jinyuan Zhou3, Jian Wang5, Meiyun Wang1.
Abstract
Amide proton transfer (APT) imaging is a noninvasive molecular magnetic resonance imaging (MRI) technique based on the chemical exchange-dependent saturation transfer mechanism. The purpose of this study was to investigate the diagnostic performance of APT MRI in detecting intracranial hemorrhage (ICH) at hyperacute, acute and subacute stages by comparing with susceptibility weighted imaging (SWI). APT MRI and SWI were performed on 33 included patients with ICH by using a 3-T MRI unit. A two-sided Mann-Whitney U test was used to detect differences in APT-weighted (APTw) and SWI signal intensities of ICH at hyperacute, acute and subacute stages. Receiver operating characteristic analysis was used to assess the diagnostic utilities of APT MRI and SWI. Our results showed that APT MRI could detect ICH at hyperacute, acute and subacute stages. Therefore, APTw signal intensity may serve as a reliable, noninvasive imaging biomarker for detecting ICH at hyperacute, acute and subacute stages. Moreover, APT MRI could provide additional information for the ICH compared with SWI.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28374764 PMCID: PMC5379544 DOI: 10.1038/srep45696
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1A 55-year-old male patient with hyperacute intracranial hemorrhage (ICH) (1 hours from stroke symptom onset) in the right basal ganglia.
The hematoma shows mixed-signal on (a) T1w image and (b) T2w image. (c) Susceptibility weighted imaging (SWI) image shows an isointense center with a hypointense periphery. (d) Amide proton transfer (APT) image shows hyperintense signal. (e) MTR(3.5 ppm) image shows hypointense signal. (f) Z spectra map. (g) Z spectra asymmetry curve map.
Figure 2A 45-year-old male patient with acute ICH (39 hours from stroke symptom onset) in the right temporal lobe.
The hematoma shows isointense signal on (a) T1w image and hyperintense signal on (b) T2w image. (c) SWI image shows a hyperintense center with a hypointense periphery. (d) APT image shows hyperintense signal. (e) MTR(3.5 ppm) image shows hypointense signal. (f) Z spectra map. (g) Z spectra asymmetry curve map.
Figure 3A 24-year-old female patient with subacute ICH (240 hours from stroke symptom onset) in the left parietal lobe.
The hematoma shows mixed-signal on (a) T1w image, (b) T2w image and (c) SWI image. (d) APT image shows hyperintense signal. (e) MTR(3.5 ppm) image shows hypointense signal. (f) Z spectra map. (g) Z spectra asymmetry curve map.
APTw, MTR(3.5 ppm) and SWI signal intensities (mean ± standard deviation) in the ICH and contralateral normal brain tissue.
| ICH stage | Normal brain tissue | Hematoma |
|---|---|---|
| Hyperacute ICH (n = 7) | ||
| APTw signal (%) | 1.2 ± 0.4 | 4.6 ± 0.8 |
| MTR(3.5 ppm) signal | 0.70 ± 0.01 | 0.58 ± 0.07 |
| SWI | 247.9 ± 28.8 | 142.8 ± 62.5 |
| Acute ICH (n = 7) | ||
| APTw signal (%) | 1.5 ± 0.4 | 3.8 ± 1.6 |
| MTR(3.5 ppm) signal | 0.71 ± 0.01 | 0.54 ± 0.09 |
| SWI | 249.9 ± 44.4 | 124.0 ± 66.7 |
| Subacute ICH (n = 19) | ||
| APTw signal (%) | 1.2 ± 0.3 | 3.2 ± 1.9 |
| MTR(3.5 ppm) signal | 0.71 ± 0.02 | 0.54 ± 0.08 |
| SWI | 243.2 ± 42.8 | 198.6 ± 149.4 |
*Significant between ICH and contralateral normal brain tissue by using a two-sided Mann-Whitney U test (p < 0.05); APTw, amide proton transfer-weighted; MTR, magnetization transfer ratio; ICH, intracranial hemorrhage; SWI, susceptibility weighted imaging.
Figure 4Receiver operating characteristic analysis.
(a) The area under the receiver operating characteristic curves for the APTw signal intensity (0.94) and the SWI signal intensity (0.94) in differentiating the ICH at acute stage from the contralateral normal brain tissue. (b) The area under the receiver operating characteristic curve of the APTw signal intensity (0.92) is greater than that of the SWI signal intensity (0.73) in identifying the subacute ICH from the contralateral normal brain tissue (p = 0.02).